tweenvest

TLC BioSciences Corp. (TPEX: 7924)

Health Care · Biotechnology · TW

NT$375.00

-2.47% today · +78.1% 1Y

Public summary
A free snapshot of TLC BioSciences Corp., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

TLC BioSciences Corp. (TPEX: 7924) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.52B.

Over the last twelve months the share price has gained 78.1%, trading between 163.00 and 503.00.

Tweenvest scores TLC BioSciences Corp. across four factors: quality 18/100, value 67/100. Its strongest factor is value.

7924 price history

Jun 26, 2026 · 210.50Weekly closes 210.50 – 473.00Nov 17, 2026 · 375.00

Key figures

Market cap
$1.52B
Revenue (TTM)
$2.47M
P/E
-22.33
EPS
-7.84
Dividend yield
—
Beta (5Y)
—
52-week high
NT$503.00
52-week low
NT$163.00
Avg volume (3M)
—
Shares outstanding
133.56M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Nanjing Vazyme Biotech Co., LtdSHSE: 688105$1.54BCN¥19.89-3.82%
Mesoblast LimitedASX: MSB$1.53BAU$1.76-1.95%
Vitrolife AB (publ)OM: VITR$1.53BSkr117.40-0.25%
Kailera Therapeutics, Inc.NasdaqGS: KLRA$1.53B$11.79-3.36%
Zhuhai Trinomab Pharmaceutical Co., Ltd.SHSE: 688806$1.52BCN¥21.97-5.02%
Voronoi, Inc.KOSDAQ: A310210$1.51B₩111,000.00+1.19%
CanSino Biologics Inc.SEHK: 6185$1.50BHK$23.34-1.85%
AlvotechNasdaqGM: ALVO$1.50B$4.19-10.28%

Browse every Biotechnology company →